StonvexLoading…
StonvexStonvexStonvexCore line items from CRVO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.01M | $9.74M | $7.14M | $0.00 |
Operating Income | $-28.29M | $-18.23M | $-7.81M | $-3.48M |
Net Income | $-26.97M | $-16.29M | $-2.17M | $-5.80M |
EPS (Diluted) | $-2.98 | $-2.02 | $-0.82 | $2038891.00 |
Total Assets | $22.88M | $43.08M | $9.97M | $4.16M |
Total Liabilities | $4.66M | $3.88M | $2.60M | $13.16M |
Cash & Equivalents | $8.24M | $9.00M | $7.79M | $4.09M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 9.25M | 8.70M | 5.67M | 518.14K |